Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature

Background. Acquired hemophilia A (AHA) is a rare condition, due to the spontaneous formation of neutralizing antibodies against endogenous factor VIII. About half the cases are associated with pregnancy, postpartum, autoimmune diseases, malignancies, or adverse drug reactions. Symptoms include seve...

Full description

Saved in:
Bibliographic Details
Main Authors: Quentin Binet, Catherine Lambert, Laurine Sacré, Stéphane Eeckhoudt, Cedric Hermans
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2017/2057019
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558765621116928
author Quentin Binet
Catherine Lambert
Laurine Sacré
Stéphane Eeckhoudt
Cedric Hermans
author_facet Quentin Binet
Catherine Lambert
Laurine Sacré
Stéphane Eeckhoudt
Cedric Hermans
author_sort Quentin Binet
collection DOAJ
description Background. Acquired hemophilia A (AHA) is a rare condition, due to the spontaneous formation of neutralizing antibodies against endogenous factor VIII. About half the cases are associated with pregnancy, postpartum, autoimmune diseases, malignancies, or adverse drug reactions. Symptoms include severe and unexpected bleeding that may prove life-threatening. Case Study. We report a case of AHA associated with bullous pemphigoid (BP), a chronic, autoimmune, subepidermal, blistering skin disease. To our knowledge, this is the 25th documented case of such an association. Following treatment for less than 3 months consisting of methylprednisolone at decreasing dose levels along with four courses of rituximab (monoclonal antibody directed against the CD20 protein), AHA was completely cured and BP well-controlled. Conclusions. This report illustrates a rare association of AHA and BP, supporting the possibility of eradicating the inhibitor with a well-conducted short-term treatment.
format Article
id doaj-art-f7a4befd323641778bd8fa4dacdf74c3
institution Kabale University
issn 2090-6560
2090-6579
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Case Reports in Hematology
spelling doaj-art-f7a4befd323641778bd8fa4dacdf74c32025-02-03T01:31:39ZengWileyCase Reports in Hematology2090-65602090-65792017-01-01201710.1155/2017/20570192057019Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the LiteratureQuentin Binet0Catherine Lambert1Laurine Sacré2Stéphane Eeckhoudt3Cedric Hermans4Hemostasis and Thrombosis Unit, Division of Hematology, Cliniques Universitaires Saint-Luc, 1200 Brussels, BelgiumHemostasis and Thrombosis Unit, Division of Hematology, Cliniques Universitaires Saint-Luc, 1200 Brussels, BelgiumDivision of Dermatology, Cliniques Universitaires Saint-Luc, 1200 Brussels, BelgiumHemostasis Laboratory, Division of Biological Chemistry, Cliniques Universitaires Saint-Luc, 1200 Brussels, BelgiumHemostasis and Thrombosis Unit, Division of Hematology, Cliniques Universitaires Saint-Luc, 1200 Brussels, BelgiumBackground. Acquired hemophilia A (AHA) is a rare condition, due to the spontaneous formation of neutralizing antibodies against endogenous factor VIII. About half the cases are associated with pregnancy, postpartum, autoimmune diseases, malignancies, or adverse drug reactions. Symptoms include severe and unexpected bleeding that may prove life-threatening. Case Study. We report a case of AHA associated with bullous pemphigoid (BP), a chronic, autoimmune, subepidermal, blistering skin disease. To our knowledge, this is the 25th documented case of such an association. Following treatment for less than 3 months consisting of methylprednisolone at decreasing dose levels along with four courses of rituximab (monoclonal antibody directed against the CD20 protein), AHA was completely cured and BP well-controlled. Conclusions. This report illustrates a rare association of AHA and BP, supporting the possibility of eradicating the inhibitor with a well-conducted short-term treatment.http://dx.doi.org/10.1155/2017/2057019
spellingShingle Quentin Binet
Catherine Lambert
Laurine Sacré
Stéphane Eeckhoudt
Cedric Hermans
Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature
Case Reports in Hematology
title Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature
title_full Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature
title_fullStr Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature
title_full_unstemmed Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature
title_short Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature
title_sort successful management of acquired hemophilia a associated with bullous pemphigoid a case report and review of the literature
url http://dx.doi.org/10.1155/2017/2057019
work_keys_str_mv AT quentinbinet successfulmanagementofacquiredhemophiliaaassociatedwithbullouspemphigoidacasereportandreviewoftheliterature
AT catherinelambert successfulmanagementofacquiredhemophiliaaassociatedwithbullouspemphigoidacasereportandreviewoftheliterature
AT laurinesacre successfulmanagementofacquiredhemophiliaaassociatedwithbullouspemphigoidacasereportandreviewoftheliterature
AT stephaneeeckhoudt successfulmanagementofacquiredhemophiliaaassociatedwithbullouspemphigoidacasereportandreviewoftheliterature
AT cedrichermans successfulmanagementofacquiredhemophiliaaassociatedwithbullouspemphigoidacasereportandreviewoftheliterature